Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.

José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health

José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing, will be the next Chair of the University of Pennsylvania School of Nursing’s (Penn Nursing) Department of Family and Community Health, effective July 1, 2020.

A Brain Link to STI/HIV Sexual Risk: Young women with Low Condom Use During Sex Find Visual Sexual Cues Less Pleasant and Less Evocative

Data show that young adult women in the United States have high rates of sexually transmitted infections (STIs) that increase their risk of HIV. Though epidemiologic and behavioral factors for risk have been studied, we know very little about brain factors that may be linked to STI/ HIV sexual risk.

Fighting the HIV Epidemic

Stigma is an important contributor to the continued HIV epidemic in the United States. While pre-exposure prophylaxis (PrEP) is a medication that can be taken to prevent HIV infection, previous research has shown that a barrier preventing gay, bisexual and other men who have sex with men from using PrEP is fear that partners, family members or community members would believe that those who use PrEP are HIV infected. Less is known, however, about these factors among women.